← Leaderboards
Ashwin N Ananthakrishnan
Massachusetts General Hospital
$4,084,397
Attributed
$6,783,314
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,783,314 · 4
By mechanism
R01$5,397,834 · 1
K23$845,980 · 1
R21$368,500 · 1
R03$171,000 · 1
Top collaborators
- Ramnik J Xavier5 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Jonathan P Winickoff$16,869,989
- Jose Carlos Florez$39,251,920
- Douglas Levy$10,993,760
- Alexander Gabriel Fiks$8,533,248
- Raymond T Chung$38,306,004
Others in their field
Top investigators on “Crohn&Apos”
- Olga Gursky · Boston University Medical Campus$598,870
- Michael Peter Vitek · Duke University$279,250
Research focus
Crohn&AposCohortPathway InteractionsAffectMorbidity - Disease RateInflammatory Bowel DiseasesUlcerative ColitisS DiseasePathogenesisProspectiveTechnologyNovel TherapeuticsFutureDisease RemissionGenesPreventTrainingAutoimmune DiseasesMachine LearningRegistriesInstitutionMicrobialInsightImmune Response
Grant awards (14)
Determinants of inception of inflammation in inflammatory bowel diseases$1,048,416
R01 · FY2025 · DK · contact PI
Determinants of inception of inflammation in inflammatory bowel diseases$1,054,797
R01 · FY2024 · DK · contact PI
Determinants of inception of inflammation in inflammatory bowel diseases$1,079,167
R01 · FY2023 · DK · contact PI
Determinants of inception of inflammation in inflammatory bowel diseases$1,085,723
R01 · FY2022 · DK · contact PI
Determinants of inception of inflammation in inflammatory bowel diseases$1,129,731
R01 · FY2021 · DK · contact PI
Differential impact of smoking on the transcriptome and epigenome in Crohn's disease and ulcerative colitis"$167,500
R21 · FY2021 · DK · contact PI
Differential impact of smoking on the transcriptome and epigenome in Crohn's disease and ulcerative colitis"$201,000
R21 · FY2020 · DK · contact PI
Genetic predictors of calprotectin response with anti-TNF and anti-integrin therapy in inflammatory bowel diseases$85,500
R03 · FY2018 · DK · contact PI
Genetic predictors of calprotectin response with anti-TNF and anti-integrin therapy in inflammatory bowel diseases$85,500
R03 · FY2017 · DK · contact PI
Genetic predictors of anti-TNF treatment response and infections in IBD$169,572
K23 · FY2016 · DK · contact PI
Genetic predictors of anti-TNF treatment response and infections in IBD$169,572
K23 · FY2015 · DK · contact PI
Genetic predictors of anti-TNF treatment response and infections in IBD$169,572
K23 · FY2014 · DK · contact PI
Genetic predictors of anti-TNF treatment response and infections in IBD$168,632
K23 · FY2013 · DK · contact PI
Genetic predictors of anti-TNF treatment response and infections in IBD$168,632
K23 · FY2012 · DK · contact PI